Log in to search using one of your social media accounts:

 

Reconstructing what makes us tick
(American Institute of Physics) A major issue that limits modeling to predict cardiac arrhythmia is that it is impossible to measure and monitor all the variables that make our hearts tick, but researchers have now developed an algorithm that uses artificial intelligence to model the electrical excitations in heart muscle. Their work, appearing in Chaos, draws on partial differential equations describing excitable media and echo state networks to cross-predict variables about chaotic electrical wave propagations in cardiac tissue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 24, 2018 Category: International Medicine & Public Health Source Type: news

You never know the life you save....become an organ donor!
The week of April 23-27 has been designated as National Pediatric Transplant Week.  This week is to bring attention to the great need for organ donations and to honor  donors and their families whose incredibly selfless gift has given someone the gift of life.While most of us will never experience the need for a transplant, there are many of us who know someone who has a debilitating condition such as kidney dialysis that are in need of a transplant.Right now there are almost 2,000 children on the national transplant list.  Those needing hearts, lungs, eyes, tissue, liver, kidney, or some other body part are...
Source: Pediatric Health Associates - April 20, 2018 Category: Pediatrics Tags: Volunteer Opportunities Source Type: news

Is Google Home a Trojan Horse in Healthcare?
In this study, recently-diagnosed diabetes patients were asked to use the technology to have "heart to heart" conversations with Alexa about what they want their friends and family to understand about their disease and what they are going through. The researchers found that patients were having genuine, meaningful conversations with Alexa about their disease, but the downside was that Alexa still sounds very robotic, which raised the question of whether or not Alexa or other voice-assisted technologies need to sound more human in order to have these types of conversations with patients and have the same impact? &...
Source: MDDI - April 19, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: BIOMEDevice Boston Digital Health Source Type: news

Heart Beats on in Transplant After Circulatory Death Heart Beats on in Transplant After Circulatory Death
The practice of transplanting organs from so-called nonbeating donors is not widely accepted, but investigators reporting promising outcomes say this could expand options for patients on wait lists.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 18, 2018 Category: Consumer Health News Tags: Transplantation News Source Type: news

LVAD Efficiency and the Criticality of Accurate Blood Pressure Measurement
What is a LVAD? How does it work? A left ventricular assist device (LVAD), also called a ventricular assist system or VAS, is a mechanical pump that is attached to the left ventricle of the heart to augment the function of the heart’s main pumping chamber. The left ventricle pumps blood from the heart to the rest of the body. It is important to note that a LVAD is different from an artificial heart. An artificial heart replaces a failing heart completely, whereas a LVAD, such as the one pictures at left developed at Proven Process, assists the heart to help pump more blood to the body with less work. The post LVAD E...
Source: Mass Device - April 18, 2018 Category: Medical Devices Authors: MassDevice Tags: White Papers Proven Process Source Type: news

Hepatitis C-infected Heart and Lung Transplants Safe Hepatitis C-infected Heart and Lung Transplants Safe
Organs donated from people infected with hepatitis C can be safely transplanted, and any transmission of the virus can be treated with antiretrovirals, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 17, 2018 Category: Consumer Health News Tags: Transplantation News Source Type: news

Heart Transplant Overuse; Urine Test for Adherence; Needling Defibrillator Pad
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - April 16, 2018 Category: Neurology Source Type: news

Inconsistent Ranking of Heart Transplant Recipients Unjust Inconsistent Ranking of Heart Transplant Recipients Unjust
It's difficult to create a system that is perfectly fair, investigators acknowledge, but the system that prioritizes heart transplants in the US according to need is not as objective as intended.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 16, 2018 Category: Consumer Health News Tags: Transplantation News Source Type: news

Molecular Diagnostics Pinpoint Heart Transplant Trouble Molecular Diagnostics Pinpoint Heart Transplant Trouble
The molecular diagnosis of biopsies to assess reduced function after heart transplant reduces errors and curbs unnecessary treatment, INTERHEART study investigators report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 12, 2018 Category: Consumer Health News Tags: Transplantation News Source Type: news

TransMedics, Inc. Receives FDA Pre-Market Approval (PMA) for its OCS(TM) Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation
ANDOVER, Mass., April 12, 2018 -- (Healthcare Sales & Marketing Network) -- TransMedics, Inc., a medical technology company that is transforming the important therapy of solid organ transplantation for patients with end-stage lung, heart and liver failure... Devices, Surgery, FDA TransMedics, Organ Care System, lung transplant, organ transplant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

TransMedics wins FDA approval for OCS Lung transplant system
TransMedics said today that it won pre-market approval from the FDA for its OCD Lung transplant system, which is designed to keep donated human lungs in near-living condition until transplantation. The March 22 approval covers standard double-lung transplantation procedures, Andover, Mass.-based TransMedics said. The federal safety watchdog granted the PMA based on data from the 316-patient Inspire trial, the results from which were published this week in The Lancet Respiratory Medicine, comparing OCS lung with the standard of care – cold flush and storage. Inspire met its primary outcome – a composite of ...
Source: Mass Device - April 12, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Regulatory/Compliance Respiratory Transplants Wall Street Beat transmedics Source Type: news

DOJ action may hinder disabled access to imaging
The U.S. Department of Justice (DOJ) has withdrawn a key guidance related to...Read more on AuntMinnie.comRelated Reading: Artificial intelligence, brain MRI aid kids with hearing loss Breast MR: Is it accessible to women who need it? Do Medicare quality measures miss the mark in radiology? HHS and DOJ warn hospitals about EHR fraud U.S. DOJ joins 'kickback' case against Ohio heart centers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 12, 2018 Category: Radiology Source Type: news

'Molecular microscope' system safer, more effective in heart and lung transplant biopsies
(University of Alberta Faculty of Medicine& Dentistry) A transplant biopsy system that uses gene chips to read molecules is far safer and more effective than existing approaches used for heart transplant biopsies and is showing promising results for lung transplant biopsies, new University of Alberta-led research shows. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 12, 2018 Category: International Medicine & Public Health Source Type: news

HeartSciences touts MyoVista LVDD study
This study of MyoVista wavelet ECG technology is a significant step towards enhancing the most commonly used low-cost, front-line tool, the 12-lead resting ECG, with new capabilities that can provide more effective risk stratification related to the early detection of heart disease,” board chair Andrew Simpson said in a prepared release. Data from the 188-patient study indicated an 80% sensitivity and 84% specificity with an area under the curve of 91% for predicting low (e’), which is used to determine LVDD. Prediction of low (e’) was identified in 82% of subjects with significant underlying coronary art...
Source: Mass Device - April 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials heartsciences Source Type: news

Better diagnosing heart transplant rejection and injury
(University of Alberta Faculty of Medicine& Dentistry) Dr. Phil Halloran and his team at the Alberta Transplant Applied Genomics Centre (ATAGC) at the University of Alberta, Edmonton, Canada, has developed a molecular system for reading heart transplant biopsies through the use of microarrays, commonly referred to as gene chips. The system promises greater accuracy in determining heart rejection and predicting future heart failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 10, 2018 Category: International Medicine & Public Health Source Type: news

Nigeria:How Mango, Banana, Plantain Cause Terminal Illnesses - Investigation
[Daily Trust] Artificial ripening of fruits with calcium carbide has continued in the country exposing consumers to high risk of developing cancer, kidney and heart diseases, Daily Trust reports. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 9, 2018 Category: African Health Source Type: news

Sharing Mayo Clinic: Defying the odds with heart-lung transplant
Aryn Clark needed a heart-lung transplant, but the wait was almost sure to be a long one. Advanced technology that did the work of her heart and lungs during that wait kept her healthy enough to be ready once transplant organs became available. Aryn Clark was born with two holes in her heart, a condition [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 8, 2018 Category: Databases & Libraries Source Type: news

Carmat updates on artificial heart pivotal trial, plans U.S. feasibility study
Carmat (EPA:ALCAR) today announced updates on its bioprosthetic artificial heart pivotal trial in Europe and said it has submitted files to the FDA seeking an early feasibility trial in the US. The Paris-based company said it has received the regulatory go-ahead to launch its European pivotal trial, looking to implant its bioprosthetic artificial heart in 20 patients with end-stage biventricular heart failure with stable health. The trial’s primary endpoint is the survival of the patients at six months. Carmat said it received clearance to run the trial in France, Kazakhstan, the Czech Republic and Denmark,...
Source: Mass Device - April 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Carmat Inc. Source Type: news

Trailblazing Transplant Research Expanding Organ Options Trailblazing Transplant Research Expanding Organ Options
Heart donation after circulatory death and new insights into the suitability of organ donations will be debated at the upcoming heart and lung transplantation scientific sessions.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 4, 2018 Category: Consumer Health News Tags: Transplantation News Source Type: news

Aziza Oubaita on the fight of her life
This 46-year-old French flyweight boxer has successfully recovered from a heart transplant. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 28, 2018 Category: Consumer Health News Source Type: news

AHA: Solving the Dilemma of Not Enough Hearts
TUESDAY, March 27, 2018 (American Heart Association) -- In the not-too-distant future, Dr. Jennifer Cowger envisions a cardiac transplant landscape where more donations are encouraged and utilized, genetically engineered organs can be created in a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 27, 2018 Category: General Medicine Source Type: news

Study: AI faster, more accurate than humans at analyzing heart scans
A form of artificial intelligence can analyze heart ultrasound tests than more quickly and better than board-certified echocardiographers, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 22, 2018 Category: Consumer Health News Source Type: news

WATCH: Chewbacca tells boy he's getting new heart
Austin Eggleston, 15, was told in a life-changing moment by his doctor, dressed as Chewbacca, that he's getting a heart transplant. (Source: ABC News: Health)
Source: ABC News: Health - March 20, 2018 Category: Consumer Health News Tags: Health Source Type: news

Man Donates Kidney To Help Save Father-In-Law ’ s Life
BOSTON (CBS) – A local man gave his father-in-law a new lease on life in the most unconventional way. Tony Darosa was busy running his printing business on Martha’s Vineyard when his wife of 50 years suggested he see a doctor. “My wife said, ‘There’s something not right,’” Darosa said. The active 70-year-old said he felt fine but did what he was told and within days he was loaded onto an ambulance and shipped to Tufts Medical Center. He was in complete kidney failure. “The bladder backed up into my kidneys and basically I guess killed them,” he explained. Tony was place...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 19, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall HealthWatch kidney donation Kidney Donors Kidney Transplant Source Type: news

AliveCor touts high precision AF detection, AI-powered hyperkalemia detection in KardiaBand studies
AliveCor this week announced results from two studies of its Apple (NSDQ:AAPL) smartphone-connected KardiaBand personal electrocardiogram device, touting the bands ability to detect atrial fibrillation and its ability to detect high potassium levels. Results from the studies, which were presented this week at the American College of Cardiology’s 67th Annual Scientific Session, provide more support to the usefulness and validity of the band as a cardiovascular health monitor, AliveCor CEO Vic Gundotra told MassDevice.com in an interview. “Doctors will read healthcare news, but until once it’s bee...
Source: Mass Device - March 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Patient Monitoring AliveCor Source Type: news

Study: Wearable AI-powered biosensors show promise for HF detection
Wearable biosenors with artificial intelligence-based analytics can provide accurate early detection of impending rehospitalization similar to implanted devices, according to data from a new study backed by the US Dept. of Veterans Affairs. The trial explored the ability of wearable sensors, developed by VitalConnect, supported by AI-driven analytics, developed by PhysIQ, to effectively predict heart failure events. Results from the trial were presented at the American College of Cardiology’s 67th annual scientific session and expo. A total of 100 subjects were enrolled across four US VA hospitals, with each provided...
Source: Mass Device - March 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Diagnostics mHealth (Mobile Health) Patient Monitoring physiq Vital Connect Source Type: news

Abbott Gains on Medtronic in LVAD Market
Abbott Laboratories said late-breaking clinical trial data from its MOMENTUM 3 clinical study shows its HeartMate 3 Left Ventricular Assist Device (LVAD) has improved survival and lowered rates of stroke and pump thrombosis. The Abbott Park, IL-based company released the data during the American College of Cardiology’s 67th Annual Scientific Sessions this past weekend. Data from MOMENTUM 3 was also published in the New England Journal of Medicine and showed patients with the HeartMate 3 LVAD had a survival rate of 82.8% at two years compared with 76.2% for those with the HeartMate II LVAD. Pump thrombosis rates remai...
Source: MDDI - March 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Magistrate judge recommends dismissal of inventor doc ’ s suit against Abbott ’ s St. Jude Medical
A federal magistrate judge in Texas last week recommended dismissal for a lawsuit brought by a physician inventor against Abbott (NYSE:ABT) subsidiarySt. Jude Medical over transcatheter valve replacement technology. Dr. Robert Snyder, founder of Snyders Heart Valve, filed suits two years ago in the U.S. District Court for Eastern Texas, claiming that both St. Jude and cross-town rival Medtronic (NYSE:MDT) used technologies covered by his patents for an artificial heart valve and delivery system called the Funnel valve, according to court documents. The lawsuits, which were later consolidated for pre-tri...
Source: Mass Device - March 12, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Patent Infringement Replacement Heart Valves Medtronic stjudemedical Source Type: news

Loomis doctor hopes to develop world ’s first permanent artificial heart
Dr. Richard Wampler is working with Oregon Health& Science University to get a total artificial heart to market. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 9, 2018 Category: Health Management Authors: Elizabeth Hayes Source Type: news

Have an (artificial) heart
(Oregon Health& Science University) Oregon Health& Science University researchers developing what they hope will be the first permanent total artificial heart. One artificial heart is already approved for human use in the US, but it's a temporary device to help patients while they wait for a human heart transplant. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 8, 2018 Category: International Medicine & Public Health Source Type: news

Abbott Proves That Size Does Matter
Abbott churned out an impressive number of new products last year, and our 2017 Medtech Company of the Year doesn't appear to be slowing down any. This week FDA approved Abbott's new pediatric mechanical heart valve, which is the first device of its kind that is small enough to be used in newborns and infants. Learn about the latest trends in medical device R&D and product development at BIOMEDevice Boston, April 18-19, 2018. Use promo code "MDDI" for 20% off conference registration and free expo access. Previously, surgeons could only use a range of larger-sized valves to replace a pediatric heart valve, Abb...
Source: MDDI - March 8, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Source Type: news

Doctors Tried Transplants Using Diseased Organs. One Year Later, the Recipients Are Still Disease-Free
More than 90,000 people in the U.S. are waiting for a kidney transplant, and new research suggests an unusual approach may help cut down the list: using diseased kidneys. In a new study published in the journal Annals of Internal Medicine, researchers gave 10 willing people, who were in need of a kidney transplant, kidneys that were infected with hepatitis-C, followed by medication known to clear the infection. All 10 remained free of the disease one year after their landmark transplants. The trial, which occurred at Johns Hopkins University School of Medicine, is one of a few happening nationwide. Currently, hepatitis-C i...
Source: TIME: Health - March 5, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized healthytime hepatitis C hepatitis-C organ transplant Johns Hopkins kidney transplant medicine Source Type: news

FDA clears robotic movement software from Corindus
The FDA granted 510(k) clearance to the first automated robotic movement software designed for Corindus Vascular Robotics (OTC:CVRS) CorPath GRX percutaneous coronary intervention platform, the company reported today. The Rotate on Retract feature allows the person operating the CorPath GRX to navigate to a targeted lesion by automatically turning the guidewire upon joystick retraction. The software also won CE Mark approval in the European Union earlier this year. Today, Dr. Nelson Bernado, the medical director of MedStar Heart Institute’s Peripheral Vascular Laboratory, is slated to perform a robotic-assited p...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Regulatory/Compliance Robotics Software / IT Vascular Corindus Vascular Robotics Source Type: news

50 Years Ago: Christiaan Barnard's Defining Moment 50 Years Ago: Christiaan Barnard's Defining Moment
Dr. David Cooper, a surgical colleague of Christiaan Barnard's in South Africa, reminisces about the first human heart transplant on the 50-year anniversary of this groundbreaking procedure.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Meet the inventor behind OHSU's permanent artificial heart
Dr. Richard Wampler's newest heart technology could prove a boon both for the sickest patients and for OHSU's the Knight Cardiovascular Institute (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 1, 2018 Category: Health Management Authors: Elizabeth Hayes Source Type: news

Meet the inventor behind OHSU's permanent artificial heart
Dr. Richard Wampler's newest heart technology could prove a boon both for the sickest patients and for OHSU's the Knight Cardiovascular Institute (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 1, 2018 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Exclusive: Inside OHSU's $20M quest to deliver the world's first permanent artificial heart to market
OHSU is one of several cardiac research centers racing to get a total artificial heart to market. While its technology is lauded, a lack of funding could stall the effort. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 28, 2018 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Exclusive: Inside OHSU's $20M quest to deliver the world's first permanent artificial heart to market
OHSU is one of several cardiac research centers racing to get a total artificial heart to market. While its technology is lauded, a lack of funding could stall the effort. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 28, 2018 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

New Cochrane Review evidence suggests that nutritional labelling on menus in restaurants and cafes may reduce our calorie intake
New evidence published in the Cochrane Library shows that adding calorie labels to menus and next to food in restaurants, coffee shops, and cafeterias could reduce the calories that people consume, although the quality of evidence is low.Eating too many calories contributes to people becoming overweight and increases the risks of heart disease, diabetes, and many cancers, which are among the leading causes of poor health and premature death.Several studies have looked at whether putting nutritional labels on food and non-alcoholic drinks might have an impact on their purchasing or consumption, but their findings have been ...
Source: Cochrane News and Events - February 27, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Honoring 50 Years of Heart Transplantation in Circulation Honoring 50 Years of Heart Transplantation in Circulation
This review explores the key milestones of the past 50 years of heart transplantation. What challenges remain, and what are some of the promising innovations on the horizon?Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 27, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Paragonix Tech wins CE Mark for heart transport devices
Paragonix Technologies said today it won CE Mark approval in the European Union for its SherpaPak and SherpaPerfusion cardiac transport systems. The SherpaPak system consists of a single-use, disposable device designed for the hypothermic static preservation and transportation of the donor hearts, while the SherpaPerfusion system is a single-use, disposable device designed for hypothermic oxygenated perfusion preservation and transport of donor hearts. “Having followed the extensive research and product development activities at Paragonix Technologies over the past few years, I am impressed by the intuitive designs o...
Source: Mass Device - February 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Regulatory/Compliance Surgical Transplants Paragonix Technologies Source Type: news

Look at this: Google AI can predict heart disease by checking eyes
Google has developed an artificial intelligence algorithm that can assess someone's risk for heart disease by looking at their retinas. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 20, 2018 Category: Consumer Health News Source Type: news

Plans for $22.5M nursing home, pediatric heart transplant program denied by state
Arnold Palmer Medical Center's $1.5 million plan gets turned down. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 19, 2018 Category: Pharmaceuticals Authors: Veronica Brezina Source Type: news

Plans for $22.5M nursing home, pediatric heart transplant program denied by state
Arnold Palmer Medical Center's $1.5 million plan gets turned down. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 19, 2018 Category: Biotechnology Authors: Veronica Brezina Source Type: news

Why Pig Organs Could Be the Future of Transplants
Making human tissue in a lab has always been more sci-fi than sci-fact, but powerful genetic technologies may change that soon. For the most part, the only way to replace diseased or failing hearts, lungs, kidneys and livers is with donor organs. Even then, many people struggle to find a good biological match with a donor, and 8,000 die each year in the U.S. while waiting for an organ. In one promising solution to the shortage, researchers have been putting a new DNA editing tool called CRISPR through rigorous tests in organ regeneration. Last August, a group of scientists led by George Church, professor of genetics at Har...
Source: TIME: Health - February 15, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthytime Longevity organ transplants Source Type: news

Why Rock Climbing May Be the Ultimate Full-Body Workout
The muscles in your hips and torso strain to hold your lower half against the wall. You arch backward and extend one hand up to clasp the next hold—your thighs and calves burning with the effort of holding you steady and in balance. A moment later, when the tips of your fingers have secured their grip, there’s a wholesale shift in the muscles you call on to maintain your safe purchase on the climbing wall. Exercise is all about engaging your muscles—from your heart to your biceps and quads—and asking those muscles to perform work. And when it comes to activating and training a diverse range of muscl...
Source: TIME: Health - February 15, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Exercise/Fitness healthytime Source Type: news

Local Woman Waits For a Heart On Valentine ’ s Day
BOSTON (CBS) — A Boston woman is waiting for a new heart this Valentine’s Day. But while her heart may be broken, she is living as though it is full. Cindy Washington was 19 and a freshman at Northeastern University pursuing a pre-law degree when she became overwhelmingly tired. “I started to lose my breath and to sweat a lot,” Cindy recalls. After many trips to the ER, doctors finally figured out her heart was enlarged, weak and failing. In fact, Cindy’s heart was so sick she went into cardiac arrest twice, both times revived by her mom. “She had to bring me to the floor and pump and re...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 15, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Heart Transplant Valentine's Day Source Type: news

Charlotte Carney has a heart that won't beat properly
Charlotte Carney, 21, from Winnington, Cheshire is running out of time because of a disorder, that makes her heart beat poorly. There is no cure - except a heart transplant. (Source: the Mail online | Health)
Source: the Mail online | Health - February 14, 2018 Category: Consumer Health News Source Type: news

21-year-old woman has a heart that won't beat properly
Charlotte Carney, 21, from Winnington, Cheshire is running out of time because of a disorder, that makes her heart beat poorly. There is no cure - except a heart transplant. (Source: the Mail online | Health)
Source: the Mail online | Health - February 14, 2018 Category: Consumer Health News Source Type: news